OXFD - オックスフォ―ド・イミュノテック・グロ―バル (Oxford Immunotec Global PLC)

OXFDのニュース

   Oxford Immunotec Global PLC Shares Near 52-Week High - Market Mover  2021/02/05 22:30:00 Kwhen Finance
Oxford Immunotec Global PLC shares closed today at 1.4% below its 52 week high of $22.29, giving the company a market cap of $570M. The stock is currently up 25.9% year-to-date, up 46.6% over the past 12 months, and up 120.7% over the past five years. This week, the Dow Jones Industrial Average rose 3.9%, and the S&P 500 rose 4.8%. Trading Activity Trading volume this week was 80.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date lags the peer average by -22.6% The company's stock price performance over the past 12 months lags the peer average by -56.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Oxford Immunotec Global PLC Shares Close in on 52-Week High - Market Mover  2021/01/29 22:30:00 Kwhen Finance
Oxford Immunotec Global PLC shares closed today at 2.0% below its 52 week high of $22.29, giving the company a market cap of $567M. The stock is currently up 25.1% year-to-date, up 34.3% over the past 12 months, and up 88.0% over the past five years. This week, the Dow Jones Industrial Average fell 3.3%, and the S&P 500 fell 3.3%. Trading Activity Trading volume this week was 71.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 0.1% lower than its 5-day moving average, 3.9% higher than its 20-day moving average, and 42.1% higher than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 9.7% The company's stock price performance over the past 12 months lags the peer average by -53.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Oxford Immunotec Global PLC Shares Near 52-Week High - Market Mover  2021/01/22 22:30:00 Kwhen Finance
Oxford Immunotec Global PLC shares closed today at 1.7% below its 52 week high of $22.29, giving the company a market cap of $568M. The stock is currently up 25.4% year-to-date, up 28.5% over the past 12 months, and up 94.1% over the past five years. This week, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 1.9%. Trading Activity Trading volume this week was 41.8% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 67.6% The company's stock price performance over the past 12 months lags the peer average by -62.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Oxford Immunotec Global PLC Shares Approach 52-Week High - Market Mover  2021/01/15 22:30:00 Kwhen Finance
Oxford Immunotec Global PLC shares closed today at 1.6% below its 52 week high of $22.29, giving the company a market cap of $569M. The stock is currently up 25.6% year-to-date, up 35.3% over the past 12 months, and up 112.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 1.5%. Trading Activity Trading volume this week was 10.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 285.4% The company's stock price performance over the past 12 months lags the peer average by -40.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Oxford Immunotec Global PLC Shares Climb 1.9% Past Previous 52-Week High - Market Mover  2021/01/07 22:30:00 Kwhen Finance
Oxford Immunotec Global PLC shares closed 1.9% higher than its previous 52 week high, giving the company a market cap of $567M. The stock is currently up 25.3% year-to-date, up 30.7% over the past 12 months, and up 111.1% over the past five years. This week, the Dow Jones Industrial Average rose 1.5%, and the S&P 500 rose 1.4%. Trading Activity Trading volume this week was 1578.4% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock priceperformance year-to-date beats the peer average by 314.0% The company's stock price performance over the past 12 months lags the peer average by -46.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC - Stocks News Feed  2021/03/09 13:00:00 Stocks News Feed
WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, today announced that the Company has completed its previously announced acquisition of Oxford Immunotec Global PLC (Oxford Immunotec). PerkinElmer originally announced its intent to acquire Oxford Immunotec on January 7, 2021. “Oxford Immunotec’s global role in fighting tuberculosis, particularly… Read More »PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC
   SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Oxford Immunotec Global PLC - OXFD  2021/01/21 20:29:00 PR Newswire
NEW YORK, Jan. 20, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is…
   OXFORD IMMUNOTEC INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oxford Immunotec Global PLC - OXFD  2021/01/14 00:20:00 Business Wire
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Oxford Immunotec Global PLC (NasdaqGS: OXFD) to PerkinElmer, Inc. (NYSE: PKI). Under the terms of the proposed transaction, shareholders of Oxford will receive only $22.00 in cash for each share of Oxford that they own. KSF is seeking to determine whether this consideration and the process that led to it are a
   The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue  2021/01/12 13:15:54 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 11) 10X Genomics Inc (NASDAQ: TXG ) AbbVie Inc (NYSE: (ABBV) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) (reacted to the company's preliminary fourth-quarter results) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Biodesix Inc (NASDAQ: BDSX ) C4 Therapeutics Inc (NASDAQ: CCCC ) CareDx Inc (NASDAQ: CDNA ) (announced preliminary fourth-quarter results) Celsius Holdings, Inc. (NASDAQ: CELH ) Chimerix Inc (NASDAQ: CMRX ) Curis, Inc. (NASDAQ: CRIS ) Dyne Therapeutics Inc (NASDAQ: DYN ) (announced positive preclinical data from its myotonic dystrophy type 1 program) Edap Tms SA (NASDAQ: EDAP ) Eli Lilly And Co (NYSE: LLY ) (announced positive data from midphase study of its investigational asset in treating early symptomatic Alzheimer's) ESSA Pharma Inc (NASDAQ: EPIX ) EXACT Sciences Corporation (NASDAQ: EXAS ) (reacted to preliminary fourth-quarter results) Eyenovia Inc (NASDAQ: EYEN ) Guardant Health Inc (NASDAQ: GH ) Johnson & Johnson (NYSE: JNJ ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Oxford Immunotec Global PLC (NASDAQ: OXFD ) Pacira Biosciences Inc (NASDAQ: PCRX ) Supernus Pharmaceuticals Inc (NASDAQ: SUPN ) Syneos Health Inc (NASDAQ: SYNH ) Theratechnologies Inc (NASDAQ: THTX ) Twist Bioscience Corp (NASDAQ: TWST ) United Therapeutics Corporation (NASDAQ: UTHR ) Vascular Biogenics Ltd (NASDAQ: VBLT ) Xencor Inc (NASDAQ: XNCR ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Jan.
   Oxford Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Oxford Immunotec Global PLC Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – OXFD  2021/01/07 21:58:00 Business Wire
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether Oxford Immunotec Global PLC (NASDAQ: OXFD) and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Oxford to PerkinElmer, Inc. for $22.00 in cash per share. On behalf of Oxford shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and infor

calendar